Document is current

Article History

Accepted: 5 January 2022

First Online: 27 January 2022

Declarations

:

: No external funding was used in the preparation of this manuscript.

: The authors Paraskevi Panagopoulou, Sonia Alexiadou, Maria Ntoumpara, Anna Papazoglou, Alexandros Makis, Athanasios Tragiannidis, and Maria Fotoulaki declare that they have no conflicts of interest relevant to the contents of this manuscript. Elpis Mantadakis has received support from Uni-pharma, maker of Hemafer-S^®, a commercially available form of intravenous iron sucrose in Greece.

: Upon request.

: The study was approved by the ethics committees of the participating hospitals.

: Applicable for the patients of the Greek cohort.

: Not applicable.

: EM and PP conceived the article, performed the literature search, and wrote the manuscript. SA, MN, and AP helped with data collection and analysis. AM, AT, and MF contributed patients to the Greek cohort and helped with preparation, review, and editing of the manuscript. All authors read and approved the final manuscript.